Medicines and Healthcare Products Regulatory Agency

(asked on 17th July 2017) - View Source

Question to the Department for Exiting the European Union :

To ask the Secretary of State for Exiting the European Union, what recent assessment the Government has made of the effect on the (a) funding and (b) staffing of the Medicines and Healthcare Products Regulatory Agency of the UK leaving the EU.


Answered by
Robin Walker Portrait
Robin Walker
This question was answered on 21st July 2017

The Department for Exiting the EU is working closely with every department to build a detailed understanding of how withdrawal will affect domestic policies and to ensure that departments are prepared for all possible negotiating outcomes. All departments are equipping themselves with the resources they need to get the best deal for the UK. As an arm's length body of the Department of Health and the National Competent Authority for the UK in the field of human and veterinary medicine, MHRA funding and staffing concerns are being considered as part of the domestic planning for withdrawal.

Reticulating Splines